Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AMGN | GILD | CELG | VRTX |
| Company | Celldex Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 36.31 | 265.72 | 65.50 | 108.01 | 393.52 |
| High | 36.62 | 271.68 | 66.35 | 108.59 | 399.68 |
| Low | 35.65 | 265.72 | 64.63 | 107.27 | 393.49 |
| Last | 36.72 | 270.05 | 65.55 | 108.24 | 399.48 |
| Change | +0.46 | +0.67 | +0.28 | +0.11 | +1.78 |
| % Change | +1.27% | +0.25% | +0.43% | +0.10% | +0.45% |
| Volume | 81,333 | 629,676 | 6,579,199 | 191,230,496 | 240,734 |
| 20-Day Average Volume | 614,483 | 2,062,876 | 6,759,225 | 16,188,930 | 920,802 |
| Previous Close | 36.26 | 269.38 | 65.27 | 108.13 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.10 | 269.98 | 68.31 | 108.17 | 401.37 |
| 20-Day Raw Stochastic | 10.94% | 39.17% | 12.17% | 63.25% | 26.91% |
| 20-Day Relative Strength | 39.43% | 45.25% | 30.68% | 64.69% | 44.06% |
| Weighted Alpha | -3.85 | +9.34 | -23.07 | +46.30 | +15.46 |
| Today's Opinion | 8% Buy | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 8% Buy | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 80% Buy | 40% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.30% since 04/19/24 | +0.32% since 04/19/24 | -1.63% since 04/19/24 | -1.97% since 11/13/19 | +1.25% since 04/19/24 |
| Low | 35.67 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 393.00 on 04/25/24 |
| High | 39.67 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -11.44% since 03/26/24 | -4.26% since 03/26/24 | -9.30% since 03/26/24 | +5.14% since 10/18/19 | -4.60% since 03/26/24 |
| Low | 35.67 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 42.38 on 03/27/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -0.62% since 01/26/24 | -13.47% since 01/26/24 | -17.41% since 01/26/24 | +13.63% since 08/20/19 | -7.20% since 01/26/24 |
| Low | 34.65 on 02/02/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 53.18 on 03/04/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +55.99% since 10/26/23 | +0.03% since 10/26/23 | -16.34% since 10/26/23 | +14.14% since 05/20/19 | +10.50% since 10/26/23 |
| Low | 22.11 on 10/30/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 53.18 on 03/04/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,026,970 | 144,488,960 | 81,266,176 | 77,035,920 | 102,789,152 |
| Shares Outstanding, K | 55,901 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 6,880,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -141,430,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 4,130,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -43,310,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.49 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 29.82 |